.png){kind=icon}
第四阶段
Reaching the market isn’t the end of the road for your molecule. Covance Phase IV solutions ensure your molecule’s potential is fully realized.
最大化您的投资组合的价值以及您的长期投资
Covance has over 30 years of experience world-wide in the late phase industry. We have deep institutional expertise across all therapeutic areas, established investigator relations and broad real world insights. This unique combination can help you define strategies and solutions to efficiently generate and communicate evidence that enables product value demonstration for various stakeholders and to:
及时履行您的审批承诺。
成功收集现实世界的证据（RWE）并延长化合物的价值。
加强您的市场立场并支持吸收。
填补差距registration要求和战略后期研究设计。
Engage with patients in meaningful ways and through Patient Reported Outcomes (PROs).
We can maximize the value of your compound through an appropriate design to strategically gather and disseminate real world data
Covance医疗和邮政营销解决方案团队将与您携带定制的解决方案，以满足您的设计，佩利和批准后需求。
Preparing for and successfully reaching the market is only the beginning of your compound’s journey. Covance combines unique perspectives and precision delivery to help you proactively plan your asset’s path to success from the start.
将数据转换为价值通信是我们所做的核心
- Understanding化合物的生命周期与德不停止signing the clinical development path to generate evidence. It is ultimately about bringing value to the healthcare community and to the patients.
- 转换the scientific and therapeutic advances to improved outcomes and communicating its value to payers and physicians is critical so patients can have fast access to your drug and get timely reimbursed for treatment.
- 连接随着世界各地的关键意见领导者和从业者，帮助您通过调查员关系团队创建和传播您的资产价值。
- 认识到通过我们的市场访问和商业化团队的市场差异，拥有专门知识，可以在全球范围内建立价值故事，以及为您当地的市场需求定制它。
通过其生命周期最大化化合物的价值
无论您是需要探索未来临床计划的设计要素，履行监管承诺，预计商业机会或对市场活动做出反应，我们了解您的挑战。我们的服务投资组合为您提供了一种策略和解决方案，以满足您的需求，包括：
- Natural history studies
- 务实的试验
- 疾病/药物注册表
- 生活质量和患者报告的结果
- Health outcomes/health economics
- Comparative effectiveness studies
- Real-world data for healthcare decision making
Deliver consistent results through tailored methodologies
Our deep strength in Health Economics Outcomes Research, Patient Reported Outcomes (PROs) instrument development, clinical epidemiology, post-marketing commitments, adherence and risk management and our access to real-world and unique data sources allows us to customize solutions that deliver the results you need. Streamlined Electronic Data Capture platforms provide high-quality cost-effective data.
Develop a strategy built on strong insights and unique access to patient and investigator’s databases
We recognize the challenges you face right up to market access and communicating your product’s value to all involved stakeholders. As your partner, we ensure you have the right strategy to strengthen your market position and maximize your ROI through:
- Our unique access to LabCorp databases via LabCorp patient centers and
- Xcellerate®专有的世界最大的调查员数据库
Both allow access to 150M de-identified patient lives in the US and 175K investigators and sites worldwide.
我们为真实世界环境中的证据生成提供了集成的解决方案，同时积极与客户进行融合，以适应他们的期望的执行策略。